Galmed Pharmaceuticals Ltd. (GLMD)
4.02
-0.28
(-6.62%)
USD |
NASDAQ |
Aug 24, 16:00
4.02
0.00 (0.00%)
After-Hours: 20:00
Galmed Pharmaceuticals Debt to Equity Ratio : 0.00 for March 31, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| March 31, 2026 | 0.00 |
| December 31, 2025 | 0.00 |
| September 30, 2025 | 0.00 |
| June 30, 2025 | 0.00 |
| March 31, 2025 | 0.00 |
| December 31, 2024 | 0.00 |
| September 30, 2024 | 0.00 |
| June 30, 2024 | 0.00 |
| March 31, 2024 | 0.00 |
| December 31, 2023 | 0.003 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.0033 |
| September 30, 2022 | 0.0057 |
| June 30, 2022 | 0.0065 |
| March 31, 2022 | 0.0075 |
| December 31, 2021 | 0.0075 |
| September 30, 2021 | 0.0073 |
| June 30, 2021 | 0.0071 |
| March 31, 2021 | 0.0053 |
| December 31, 2020 | 0.0049 |
| September 30, 2020 | 0.0046 |
| June 30, 2020 | 0.0042 |
| March 31, 2020 | 0.0047 |
| Date | Value |
|---|---|
| December 31, 2019 | 0.005 |
| September 30, 2019 | 0.005 |
| June 30, 2019 | 0.0054 |
| March 31, 2019 | 0.0059 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.023 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| BioLineRx Ltd. | 0.544 |
| XTL Biopharmaceuticals Ltd. | -- |
| Kamada Ltd. | 0.0438 |
| Can-Fite BioPharma Ltd. | -- |
| Revium Recovery, Inc. | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 16.03M |
| Total Liabilities (Quarterly) | 2.079M |
| Shareholders Equity (Quarterly) | 13.95M |
| Current Ratio | 7.709 |